WCP
XENT

Welch Capital Partners’s Intersect ENT, Inc XENT Stock Holding History

Welch Capital Partners’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-66,084
Closed -$854K – 46
2016
Q2 		$854K Buy
+66,084
New +$1.03M 0.31% 35

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Welch Capital Partners's XENT Position: Q3 2016 in Review

Welch Capital Partners sold out of Intersect ENT, Inc (XENT) in Q3 2016, closing a stake of 66,084 shares — an estimated $854K sold.

Welch Capital Partners first reported a position in XENT in Q2 2016 and held it in 1 quarter. The position peaked at $854K in Q2 2016. 98 funds tracked by Wall St. Rank hold XENT as of Q3 2016.

  • Welch Capital Partners reported no remaining Intersect ENT, Inc position as of Q3 2016 after selling out during the quarter.
  • Welch Capital Partners sold 66,084 Intersect ENT, Inc shares in Q3 2016, an estimated $854K.
  • Welch Capital Partners first reported a position in Intersect ENT, Inc in Q2 2016 and held it in 1 quarter.
  • Welch Capital Partners's Intersect ENT, Inc position peaked at $854K in Q2 2016.
  • 98 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2016.

Based on Welch Capital Partners's 13F filing for Q3 2016, filed 27 Oct 2016.